Earth Science Tech, Inc. (OTC: ETST), a strategic holding company focused on a diversified portfolio, has announced the acquisition of Zoolzy LLC, a wholesale distributor of active pharmaceutical ingredients (APIs) and finished FDA-approved prescription products based in Doral, Florida. This move is set to integrate Zoolzy into ETST's supply chain, enabling its compounding pharmacies to procure APIs at competitive wholesale pricing, which the company says could increase overall profit margins.
The acquisition is a strategic step for ETST as it seeks to build a vertically integrated healthcare platform. Zoolzy operates from a 3,684-square-foot facility and is expected to provide ETST with broader access to novel APIs for custom compounding, as well as immediate procurement access to common veterinary medications. This aligns with ETST's plans to leverage the new supply line to expand into the animal health market with unique, flavored, and easy-to-administer veterinary therapeutics, an initiative led by members of its management team with experience and established networks in the exotic wildlife space.
This development is significant for ETST because it addresses two key areas: cost efficiency and market diversification. By securing APIs at wholesale prices, the company can improve its margins on compounded medications, which is crucial in a competitive healthcare environment. Additionally, entering the veterinary market opens up a new revenue stream, particularly in the niche of exotic wildlife therapeutics, where there may be less competition and higher demand for specialized products.
The acquisition also reflects ETST's broader strategy of building a seamless integration of patient care, from consultation to fulfillment, through the synergy of specialized subsidiaries. With the addition of Zoolzy, ETST strengthens its supply chain capabilities, which is a critical component of its operational model. The company's core value proposition is to provide a holistic healthcare experience, and having a reliable and cost-effective source of APIs is essential to that mission.
Investors and industry observers will be watching to see how ETST integrates Zoolzy into its existing operations and whether the expected margin improvements and veterinary market expansion materialize. The acquisition is a clear signal that ETST is actively pursuing growth opportunities to enhance shareholder value and solidify its position in the health and wellness sector.
For more information about Earth Science Tech, visit the company's newsroom at https://ibn.fm/ETST.
